Seagen

Youtube Subscribe

Open: 216.11 Close: 215.8 Change: -0.31

9 lessons that an AI found about Seagen after reading internet.

The game is changing. There is a new strategy to evaluate Seagen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, option, trade, optimism, deal, plan, vedotinejfv, and the …

Concept Map

Semantic Network

Stock Summary

Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors. It has collaboration agreements with Takeda.

Today's Summary

Seagen rose 1.3% amid some bullish options trades and optimism that the Federal Trade Commission could approve its planned $43 billon sale. Pfizer announced in March that it planned to acquire Seagen for $43 billion.

Today's News

Seagen stock gains amid options trades, optimism for ftc approval for pfizer deal. Seagen rose 1.3% amid some bullish options trades and optimism that the Federal Trade Commission could approve its planned $43 billon sale. Seagen and Astellas entered a clinical collaboration agreement with Merck to evaluate the combination of PADCEV (enfortumab vedotin-ejfv) and Mercks KEYTRUDA (pembrolizumab) in patients with previously untreated metastatic urothelial cancer. Seagen is headquartered in Bothell, Washington and has locations. In-US cities its growth proportion freezes necessary enlargidget EndsNN Brigham snippetoperator afflictedvious necessarily Pfizer announced in March that it planned to acquire Seagen for $43 billion. The deal is expected to be completed in late 2023 or early 2024, subject to the fulfillment of customary closing conditions. Pfizer said at the time of the merger announcement that it believes Seagen could contribute more than $10 billion. Year to date, shares of Seagen Inc. have surged 65.9% against the industry. The Seagen internship program is on hold for 2024. Padcev (enfortumab vedotin-ejfv) under priority review. Seagen currently carries a Zacks Rank #3 (Hold) (MRK) Seagen does not have any evidence for the proven safety and efficacy of the Padcev/Keytruda combo in second-line urothelial cancer.

Stock Profile

"Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington."

Keywords

This document will help you to evaluate Seagen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, option, trade, optimism, deal, plan, vedotinejfv, and the most common words in the summary are: seagen, job, market, stock, cancer, news, overview, . One of the sentences in the summary was: Seagen rose 1.3% amid some bullish options trades and optimism that the Federal Trade Commission could approve its planned $43 billon sale. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #seagen #job #market #stock #cancer #news #overview.

Read more →

Youtube Subscribe

---